Search Legislation

Advanced Search

Commission Regulation (EU) No 722/2012Show full title

Commission Regulation (EU) No 722/2012 of 8 August 2012 concerning particular requirements as regards the requirements laid down in Council Directives 90/385/EEC and 93/42/EEC with respect to active implantable medical devices and medical devices manufactured utilising tissues of animal origin (Text with EEA relevance)

Help about what version

What Version

Close

This is a legislation item that originated from the EU

After exit day there will be three versions of this legislation to consult for different purposes. The legislation.gov.uk version is the version that applies in the UK. The EU Version currently on EUR-lex is the version that currently applies in the EU i.e you may need this if you operate a business in the EU.

The web archive version is the official version of this legislation item as it stood on exit day before being published to legislation.gov.uk and any subsequent UK changes and effects applied. The web archive also captured associated case law and other language formats from EUR-Lex.

Changes to legislation:

Commission Regulation (EU) No 722/2012 is up to date with all changes known to be in force on or before 27 April 2024. There are changes that may be brought into force at a future date. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. Changes and effects are recorded by our editorial team in lists which can be found in the ‘Changes to Legislation’ area. Where those effects have yet to be applied to the text of the legislation by the editorial team they are also listed alongside the affected provisions when you open the content using the Table of Contents below.

View outstanding changes

Changes and effects yet to be applied to :

  • Regulation applied by S.I. 2002/618, reg. 4K(2)(4) (as inserted) by S.I. 2019/791 reg. 3(7) (This amendment not applied to legislation.gov.uk. The affecting text in reg. 3(7) is omitted (31.12.2020 immediately before IP completion day) by virtue of S.I. 2020/1478, reg. 1(3), Sch. 2 para. 9(h))
  • Regulation applied by S.I. 2002/618, reg. 4K(3) (as inserted) by S.I. 2019/791 reg. 3(7) (This amendment not applied to legislation.gov.uk. The affecting text in reg. 3(7) is omitted (31.12.2020 immediately before IP completion day) by virtue of S.I. 2020/1478, reg. 1(3), Sch. 2 para. 9(h))
  • Regulation revoked by S.I. 2002/618, reg. 4K (as substituted) by S.I. 2021/873 Sch. 1 para. 4

  1. Introductory Text

  2. Article 1.(1) This Regulation lays down particular requirements in relation to...

  3. Article 2.For the purposes of this Regulation, the following definitions apply...

  4. Article 3.(1) Before lodging an application for a conformity assessment for...

  5. Article 4.(1) The Secretary of State must verify on a regular...

  6. Article 5.(1) Conformity assessment procedures for medical devices referred to in...

  7. Article 6.Without prejudice to Article 7(2), Member States shall take all...

  8. Article 7.(1) Holders of EC design-examination certificates or EC type-examination certificates...

  9. Article 8.Directive 2003/32/EC is repealed with effect from 29 August 2013....

  10. Article 9.This Regulation enters into force on the twentieth day following...

  11. Signature

    1. ANNEX I

      1. 1. RISK ANALYSIS AND RISK MANAGEMENT

        1. 1.1. Justification for the use of animal tissues or derivatives

        2. 1.2. Process of risk assessment

          1. 1.2.1. Animals as a source of material

          2. 1.2.2. Geographical sourcing

          3. 1.2.3. Nature of starting tissue

          4. 1.2.4. Slaughtering and processing controls to prevent cross contamination

          5. 1.2.5. Inactivation or removal of TSE infectious agents

            1. 1.2.5.1. For devices which cannot withstand an inactivation or elimination process...

            2. 1.2.5.2. For other devices, if claims are made by the manufacturer...

          6. 1.2.6. Quantities of animal tissues or derivatives required to produce one...

          7. 1.2.7. Tissues or derivatives of animal origin coming into contact with...

          8. 1.2.8. Route of administration

        3. 1.3. Review of the risk assessment

      2. 2. EVALUATION BY APPROVED BODIES

        1. 2.1. Information of the Approved Body regarding changes and new information...

        2. 2.2. Renewal of certificates

        3. 2.3. Increase of the overall TSE risk

      3. 3. RIGOROUS PROCESSES FOR TALLOW DERIVATIVES AS REFERRED TO IN ARTICLE...

    2. ANNEX II

      Details relating to the submitting approved body

      1. Details relating to the submitting notified body

        1. 1. Name of approved body

        2. 2. Approved body number

        3. 3. Country

        4. 4. Sent by

        5. 5. Contact person

        6. 6. Telephone

        7. 7. Fax

        8. 8. E-mail

        9. 9. Client reference (name of manufacturer and, if applicable, of authorised...

        10. 10. Confirmation that the submitting approved body has been designated by...

      2. Data relating to the (active implantable) medical device

        1. 11.  Active implantable medical device  Other medical device

        2. 11. Product description and composition

        3. 12. Information on intended use

        4. 13. Starting material

          1. 13. EDQM certificate available  YES  NO (If the EDQM...

          2. 13. Information regarding the nature of the starting tissue(s): animal species(s):...

        5. 14. A description of the key elements adopted to minimise the...

        6. 15. An estimate of the TSE risk arising from the use...

        7. 16. A justification for the use of animal tissues or derivatives...

        8. 17. The approach to the auditing of source establishments and suppliers...

      3. Approved Body Statement

        1. 18. Conclusion of this assessment:

      4. Date of submission

        1. 19. This report was sent on … to the Coordinating Competent...

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.

The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.

For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources